2019
DOI: 10.1016/j.bioorg.2019.03.059
|View full text |Cite
|
Sign up to set email alerts
|

Antiproliferative effect, cell cycle arrest and apoptosis generation of novel synthesized anticancer heterocyclic derivatives based 4H-benzo[h]chromene

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
14
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 48 publications
(14 citation statements)
references
References 45 publications
0
14
0
Order By: Relevance
“…New 2-substituted 4H-benzo[h]chromenes and 7H-benzo[ h ]chromeno[2,3–d] pyrimidines were prepared by Alblewi et al ( 2019b ) and assessed their in-vitro anticancer activity. As a result, compounds 30 and 31 (IC 50 value 0.45 and 3.8 μg/mL, respectively) showed 13.6 and 1.6 times more cytotoxicity than vinblastine (IC 50 6.1 μg/mL), though compound 30 has the similar activity as doxorubicin, with an IC 50 value of 0.4 μg/mL against MCF-7.…”
Section: Biological Activities Of 2h/4h-chromenesmentioning
confidence: 99%
See 1 more Smart Citation
“…New 2-substituted 4H-benzo[h]chromenes and 7H-benzo[ h ]chromeno[2,3–d] pyrimidines were prepared by Alblewi et al ( 2019b ) and assessed their in-vitro anticancer activity. As a result, compounds 30 and 31 (IC 50 value 0.45 and 3.8 μg/mL, respectively) showed 13.6 and 1.6 times more cytotoxicity than vinblastine (IC 50 6.1 μg/mL), though compound 30 has the similar activity as doxorubicin, with an IC 50 value of 0.4 μg/mL against MCF-7.…”
Section: Biological Activities Of 2h/4h-chromenesmentioning
confidence: 99%
“…All these compounds showed early and late apoptosis after the exposure under Annexin V/PI double staining. Thus, an in-vitro study showed that compounds 32 , 33 , and 30 had the potency to inhibit cancer, but in the respect of in-vivo study, further investigations are required to clarify the actual potency inside the systemic circulation (Alblewi et al, 2019b ).…”
Section: Biological Activities Of 2h/4h-chromenesmentioning
confidence: 99%
“…Among the most significant heterocyclics are the substituted chromenes and benzochromenes, owing to their antimicrobial [1-5], antiviral, anti-HIV, antileishmanial, antianaphylactic [6][7][8], anticancer [9][10][11][12][13][14][15][16], anti-inflammatory [17,18] and antioxidant [19] applications. β-enaminonitriles containing 4H-benzo[h]chromene systems have been used in cancer treatment approaches; therefore, they are described as prospective cancer pharmaceuticals' targets.…”
Section: Introductionmentioning
confidence: 99%
“…Meanwhile, fused benzochromenes are also valuable as effective anticancer agents; for instance, the 9amino/benzylideneamino and 8-amino/imino derivatives of benzochromenopyrimidine and benzochromenopyrimidin-8-one, respectively, are found to be effective against caspase 3/7 activators and targets for cell cycle study [5,11]. Furthermore, the cell cycle was arrested in the 9-amino/methyl derivative of 7-(2,4/3,4-dimethoxyphenyl)benzochromenopyrimidine, responsible for apoptosis, caspase 3/7 activation, DNA breakage, cell invasion and migration [13,14]. Overexpression of ABC transporters such as P-glycoprotein (P-gp), multidrug resistance protein 1 (MDR1) and ATP-binding cassette subfamily B member 1 (ABCB1) is the main contributor to MDR [26,27].…”
Section: Introductionmentioning
confidence: 99%
“…Several other derivatives of I and II were also identi ed as effective antimicrobial agents [8], anticancer agents [9][10][11][12], c-Src kinase inhibitors [13], antioxidants [14], Xanthine oxidase inhibitors [15], etc. In addition, N-substituted as well as 2,3-heterocyclic fused analogs of I were reported to have wide variety of biological applications [16][17][18][19][20]. Structures of the compounds I and II and their derivatives with their pharmacological applications has been given in Fig.…”
Section: Introductionmentioning
confidence: 99%